Close Menu

SAN FRANCISCO (GenomeWeb) – Grail said this week that it will begin a new clinical study for early cancer detection in collaboration with University College London and the University College London Hospitals NHS Foundation Trust. The study aims to enroll 50,000 people, half of them at risk for lung cancer based on a history of smoking.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.